drugset / Trial / NCT02517905

Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

NCT02517905

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Phase 3, randomized, double-blind, placebo-controlled study in subjects scheduled to undergo elective bilateral third molar extraction under local anesthesia. At least one lower mandibular third molar must involve full or partial bony impaction confirmed by visual or radiographic evidence.

Timeline

Start
2015-08
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 133 mg Other

Indications